Efficacy and Safety of XG-104 for the Treatment of Dry Eye
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and efficacy of XG-104 Ophthalmic
Solution compared to placebo for the treatment of the signs and symptoms of dry eye after a 4
week Three Times a Day (TID) treatment period